Know Cancer

or
forgot password

Medico-economic Evaluation Comparing Conformal Radiotherapy With Intensity Modulation (IMRT) Performed by, Helical Tomotherapy (Hi Art) and Dynamic Arc Therapy (RapidArc, VMAT) in Cancers With Pelvic Lymph Node Irradiation (Prostate, Cervix, Anal Canal)


N/A
18 Years
N/A
Open (Enrolling)
Both
Prostate Cancer, Cervical Cancer, Anal Canal Cancers

Thank you

Trial Information

Medico-economic Evaluation Comparing Conformal Radiotherapy With Intensity Modulation (IMRT) Performed by, Helical Tomotherapy (Hi Art) and Dynamic Arc Therapy (RapidArc, VMAT) in Cancers With Pelvic Lymph Node Irradiation (Prostate, Cervix, Anal Canal)


Inclusion Criteria:



- WHO performance index ≤ 2

- Age > 18 years

- histologically proven carcinoma: Anal canal cancer locally advanced (> 4 cm and / or
N1 to N3) under irradiation on pelvic and inguinal lymph nodes with concurrent
chemotherapy. The boost with brachytherapy are accepted Prostate cancer with pelvic
lymph nodes and radiation or hormone therapy Cervical Cancer under a purely medical
treatment involving irradiation on pelvic lymph nodes and primary tumor with
concurrent chemotherapy without surgery. The Boost by external radiotherapy or
brachytherapy are accepted.

- The investigator must ensure that the patient has not expressed its opposition to
participate in this study. The signing of a consent form is optional;

Exclusion Criteria:

- History of invasive cancer other than basal cell carcinomas.

- Indication of re-irradiation

- para-aortic radiotherapy associated with pelvic irradiation.

- post-operative radiotherapy.

- geographical distance

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label

Outcome Measure:

Medico-economic study : medical cost differential between 3 ways of Radiotherapy by IMRT (helical tomotherapy and dynamic arc therapy : RapidArc and VMAT).

Outcome Description:

Costs of the devices, maintenance costs ; personnel costs directly related to the medical therapeutic procedure (physicians, medical physicists, dosimetry, technicians).

Outcome Time Frame:

2 months

Safety Issue:

No

Authority:

France : French Health Products Safety Agency (AFSSAPS)

Study ID:

BRD 10/12-O

NCT ID:

NCT01325961

Start Date:

March 2011

Completion Date:

Related Keywords:

  • Prostate Cancer
  • Cervical Cancer
  • Anal Canal Cancers
  • prostate, cervical and anal canal cancers with pelvic lymph node irradiation
  • Uterine Cervical Neoplasms
  • Prostatic Neoplasms
  • Anus Neoplasms

Name

Location